Because of the occurrence of genotype 3 hepatitis E virus (HEV) in regions of low endemicity, it is important to validate the currently used serological assays for diagnosing infections with viruses belonging to this lineage, since these assays only use antigens derived from genotype 1 and 2 viruses. We evaluated the Genelabs enzyme-linked immunosorbent assay (ELISA) and the RecomBlot from Mikrogen for the detection of HEVspecific immunoglobulin M (IgM) and IgG under conditions of low endemicity. We compared test results of 16 patients with locally acquired genotype 3 HEV, 8 genotype 1 patients, 167 healthy controls from the general population, and 101 cases with hepatitis due to other viral causes. The measured specificities of the ELISA (98%) and the RecomBlot (97%) were comparable to those given by the manufacturer for IgM but were significantly lower for IgG (93% by ELISA and 66% by immunoblotting, versus reported values of 98% for ELISA and 95% for blotting). Antibody levels detected following infections with genotype 3 were lower than those following genotype 1 infections except for those measured in the IgM ELISA. Reactivity to the four antigens used in the immunoblot assay were analyzed and showed differences in the IgM immunoblot reactions between genotype 1 patients and genotype 3 patients. The ORF3 antigen was the most specific antigen. The specificity could be improved by a combined testing regimen with confirmation by immunoblotting of all positive ELISA results and by raising the cutoff of the IgG immunoblot assay without loss of sensitivity. We conclude that a combination of ELISA and immunoblotting is needed for acceptable specificity and sensitivity of HEV assays under conditions of low endemicity.Hepatitis E is an acute self-limiting disease that is common in Asia and Africa and considered emerging in many industrialized countries. After the discovery of the hepatitis E virus (HEV) by electron microscopy in 1983 and its subsequent characterization (2), HEV infections have been reported over a wide geographic area in Asia, Africa, the Middle East, and Central America (1). The lineages that are endemic in these regions differ antigenically and genetically and have been labeled Birma-like (genotype 1), Mexico-like (genotype 2), and China-like (genotype 4). In addition, besides travel-associated HEV infections, several reports have now shown indigenous circulation of a fourth lineage of HEV (genotype 3), both in humans and in swine in regions of the world previously considered free from HEV (3,8,10,(13)(14)(15)(16)(17).HEV infections are recognized in The Netherlands as an imported disease related to travel to regions of endemicity but also as a result of indigenous transmission of HEV. In the travel-related cases, genotype 1 is frequently detected, whereas most locally acquired HEV cases are caused by genotype 3 viruses. In view of the increasing awareness of the occurrence of HEV in regions with a temperate climate, it is important to validate the currently used serological assays for diagnosis o...